Neurocrine Biosciences NBIX
NASDAQ NBIX
$153.54 -1.99 (-1.28%)
At close: Aug 20, 2026 · 2:01 PM UTC

Neurocrine Biosciences (NBIX) Prepaid Assets (2010 - 2026)

Neurocrine Biosciences (NBIX) posted quarterly Prepaid Assets of $217.1 million for Q2 2026, up 79.87% year-over-year from $120.7 million in Q2 2025, and down 3.43% on a QoQ basis from $224.8 million in Q1 2026.

Neurocrine Biosciences (NBIX) Prepaid Assets (2010 - 2026) Analysis & Trends

Neurocrine Biosciences has reported Prepaid Assets for 17 years, with the latest figure at $217.1 million in Q2 2026.

  • Prepaid Assets for Q2 2026 came in at $217.1 million, up 79.87% year-over-year; the trailing twelve-month figure through Jun 2026 was $217.1 million (up 79.87% YoY), and the FY2025 annual result was $170.7 million, up 168.4% from the prior year.
  • Prepaid Assets fell to $217.1 million in Q2 2026, from $224.8 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $224.8 million in Q1 2026 and troughed at $60.8 million in Q1 2022.
  • A 5-year average of $118.2 million and a median of $110.7 million in 2023 frame the typical range for Prepaid Assets.
  • The widest annual swing landed in 2024, when Prepaid Assets slumped 34.97%; it then surged 168.4% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $79.1 million in 2022, then rose by 23.64% to $97.8 million in 2023, then slumped by 34.97% to $63.6 million in 2024, then soared by 168.4% to $170.7 million in 2025, then rose by 27.18% to $217.1 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $217.1 million in Q2 2026, $224.8 million in Q1 2026, and $170.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 217.10 Mn
Mar 31, 2026 224.80 Mn
Dec 31, 2025 170.70 Mn
Sep 30, 2025 68.20 Mn
Jun 30, 2025 120.70 Mn
Mar 31, 2025 119.30 Mn
Dec 31, 2024 63.60 Mn
Sep 30, 2024 121.70 Mn
Jun 30, 2024 120.20 Mn
Mar 31, 2024 100.50 Mn
Dec 31, 2023 97.80 Mn
Sep 30, 2023 108.20 Mn
Jun 30, 2023 100.60 Mn
Mar 31, 2023 113.20 Mn
Dec 31, 2022 79.10 Mn
Sep 30, 2022 67.90 Mn
Jun 30, 2022 62.70 Mn
Mar 31, 2022 60.80 Mn
Dec 31, 2021 45.50 Mn
Sep 30, 2021 50.50 Mn